Mark S. George
Medical University of South Carolina, American University in Cairo
Papers
3
Total Citations
1,680
H-Index
3
About
Mark S. George is a pioneering figure in the field of transcranial magnetic stimulation (TMS), whose work has fundamentally shaped the clinical application of this technology for treating neuropsychiatric disorders. His primary research areas focus on the safety, efficacy, and regulatory evolution of TMS, particularly for major depressive disorder (MDD). George’s most significant contribution is his leadership in establishing the international safety guidelines for TMS use in healthy subjects and patient populations, a consensus document that has garnered over 1,470 citations and remains the gold standard for clinical practice. He also authored a comprehensive visual timeline of US FDA milestones for TMS devices (205 citations), chronicling the technology’s journey from initial approval for treatment-resistant MDD to broader applications. Beyond these landmark papers, George’s work has been instrumental in bridging the gap between neurostimulation research and real-world clinical implementation, influencing both regulatory policy and therapeutic protocols. His achievements include serving as a key advisor to the International Federation of Clinical Neurophysiology and driving the adoption of TMS as a mainstream intervention for depression. For students and researchers, George’s career exemplifies how rigorous safety research can translate into life-changing medical technologies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3